An Open Platform urgently needed for
testing in Low- & Middle-Income Countries

Sample-to-result molecular diagnostic platforms and their suitability for infectious disease testing in low- and middle-income countries

Diagnostics are an essential, undervalued part of the health-care system. For many diseases, molecular diagnostics are the gold standard, but are not easy to implement in Low- and Middle-Income Countries (LMIC).

15th July 2024

Share this news

Fast MDx provides fast, full automated testing

Find out more